From Nasdaq, Inc.:

The top picks in healthcare for income-seeking investors are Dividend Kings, which are companies that have increased their payouts for at least 50 consecutive years. Abbott Laboratories and Johnson & Johnson are two such companies worth considering. Abbott Laboratories had a tough year in 2023, but excluding their COVID segment, the company’s revenue organic growth increased by 11.6%. This shows potential for the company’s future in the healthcare industry. As for Johnson & Johnson, the company remains financially strong with a 6.5% sales increase in 2023 and has a track record of raising dividends for 61 years. Both companies have potential for investors seeking reliable income from their investments.



Read more: 2 Healthcare Dividend Kings to Buy and Hold Forever